# Eleven Biotherapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/eleven-biotherapeutics

- Industry: Pharmaceuticals
- Headquarters: Cambridge, US
- Website: www.elevenbio.com
- Total disclosed funding: $29M
- Latest round: Series A (May 8, 2012)
- Investors on record: 3

## About

Eleven Biotherapeutics, Inc. is a biotechnology company focused on developing novel therapeutics for diseases, leveraging its expertise in protein engineering and drug delivery to create innovative treatments.Founded in 2008 and headquartered in Cambridge, US, Eleven Biotherapeutics specializes in biotherapeutic development. The company has made five significant deals to date, including a recent Private Placement/Follow on funding round where it raised USD 8.00 mn on November 3, 2017. The founder, who previously established other ventures, has steered the company towards innovative drug solutions.Eleven Biotherapeutics develops biotherapeutics aimed at addressing significant unmet medical needs. Its focus includes novel protein-based therapeutics designed to enhance treatment efficacy and patient outcomes in various disease areas.In the most recent fiscal year 2024, Eleven Biotherapeutics reported a revenue of USD 19.63 mn, with an EBITDA of USD -58.83 mn, reflecting the company’s ongoing investment in R&D.Eleven Biotherapeutics aims to expand its product pipeline with several new biotherapeutics currently under development, specifically targeting therapies for serious diseases. The company plans to extend its reach into new markets, specifically targeting regions in Europe and Asia by 2025. The recent funding of USD 8.00 mn will be utilized to accelerate these development efforts and support strategic market entries.

## Funding rounds

- Series A, May 8, 2012, $20M — Flagship Pioneering, JAFCO Group, Third Rock Ventures
- Series A, Feb 17, 2010, $8.8M — Flagship Pioneering, Third Rock Ventures

## Investors

- Flagship Pioneering (https://capitalatlas.ai/funds/flagship-pioneering) — Series A
- Third Rock Ventures (https://capitalatlas.ai/funds/third-rock-ventures) — Series A
- JAFCO Group (https://capitalatlas.ai/funds/jafco-group) — Series A